Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137,955 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis.
Yang J, Liu X, Zhong QZ, Yang Y, Wu T, Chen SY, Chen B, Song YW, Fang H, Wang SL, Liu YP, Jin J, Li N, Lu NN, Jing H, Tang Y, Chen F, Zhang XM, Zhang W, Zhai Y, Qi SN, Li YX. Yang J, et al. Among authors: liu x, liu yp. Cancer Lett. 2024 Jul 28;595:216793. doi: 10.1016/j.canlet.2024.216793. Epub 2024 Mar 19. Cancer Lett. 2024. PMID: 38513800
Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis.
Wang J, Liu X, Wu Y, Zhong Q, Wu T, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu Y, Song Y, Fang H, Lu N, Li N, Zhai Y, Zhang W, Deng M, Wang S, Chen F, Yin L, Hu C, Qi S, Li Y. Wang J, et al. Among authors: liu y, liu x. J Natl Cancer Cent. 2024 Apr 23;4(3):249-259. doi: 10.1016/j.jncc.2024.04.002. eCollection 2024 Sep. J Natl Cancer Cent. 2024. PMID: 39281722 Free PMC article.
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma.
Luo F, Zhong QZ, Liu X, Hou XR, Qian LT, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, He X, Zhang LL, Qu BL, Yang Y, Hu C, Deng M, Wang SL, Qi SN, Li YX. Luo F, et al. Among authors: liu x. Ther Adv Med Oncol. 2024 Oct 1;16:17588359241285981. doi: 10.1177/17588359241285981. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39399411 Free PMC article.
Targeting RSK2 in Cancer Therapy: A Review of Natural Products.
Wu T, Chen Z, Liu X, Wu X, Wang Z, Guo W. Wu T, et al. Among authors: liu x. Anticancer Agents Med Chem. 2024 Sep 6. doi: 10.2174/0118715206329546240830055233. Online ahead of print. Anticancer Agents Med Chem. 2024. PMID: 39248063
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study.
Zhang L, Meng L, Liu B, Zhang Y, Zhu H, Cui J, Sun A, Hu Y, Jin J, Jiang H, Zhang X, Li Y, Liu L, Zhang W, Liu X, Gu J, Qiao J, Ouyang G, Liu X, Luo J, Jiang M, Xie X, Li J, Zhao C, Zhang M, Yang T, Wang J. Zhang L, et al. Among authors: liu x, liu l, liu b. Clin Cancer Res. 2021 Jan 1;27(1):70-77. doi: 10.1158/1078-0432.CCR-20-1600. Epub 2020 Sep 14. Clin Cancer Res. 2021. PMID: 32928796
137,955 results
You have reached the last available page of results. Please see the User Guide for more information.